Julphar to Build Pharmaceutical Plant in Jeddah, Awsat Says
Gulf Pharmaceutical Industries, also known as Julphar, signed an agreement with Cigalah Group to build a pharmaceutical plant in Jeddah, Asharq al-Awsat reported, citing Julphar’s Chairman Faisal Al Qasimi.
The plant, with an investment of $40 million, will start commercial production in 2014, the newspaper said.
To contact the reporter on this story: Mourad Haroutunian in Riyadh at email@example.com
To contact the editor responsible for this story: Shaji Mathew at firstname.lastname@example.org
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.